<?xml version="1.0" encoding="UTF-8"?>
<ref id="B38-pathogens-09-00331">
 <label>38.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tan</surname>
    <given-names>E.L.</given-names>
   </name>
   <name>
    <surname>Ooi</surname>
    <given-names>E.E.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>C.-Y.</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>H.C.</given-names>
   </name>
   <name>
    <surname>Ling</surname>
    <given-names>A.E.</given-names>
   </name>
   <name>
    <surname>Lim</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Stanton</surname>
    <given-names>L.W.</given-names>
   </name>
  </person-group>
  <article-title>Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs</article-title>
  <source>Emerg. Infect. Dis.</source>
  <year>2004</year>
  <volume>10</volume>
  <fpage>581</fpage>
  <lpage>586</lpage>
  <pub-id pub-id-type="doi">10.3201/eid1004.030458</pub-id>
  <pub-id pub-id-type="pmid">15200845</pub-id>
 </element-citation>
</ref>
